Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 10:18:e18743064279064.
doi: 10.2174/0118743064279064231227070344. eCollection 2024.

Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines Reviewed

Munish Sharma  1 , Sushil Joshi  2 , Prakash Banjade  3 , Shekhar A Ghamande  4 , Salim Surani  4
Affiliations
Review

Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines Reviewed

Munish Sharma et al. Open Respir Med J. .

Abstract

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report is an essential resource for all clinicians who strive to provide optimal care to patients with chronic obstructive lung disease (COPD). The annual report of GOLD makes few revisions and updates besides including data from the preceding year. At an interval, GOLD comes up with a significant modification in its guidelines, which is generally a major overhaul of the pre-existing guidelines. According to the latest 2023 updates, published in November 2022, there have been significant advancements made in the field of COPD. These include the development of more precise definitions for COPD and its exacerbations, the introduction of a new set of parameters to measure exacerbation severity, and updating the COPD assessment tool. Additionally, revisions have been made to the initial and follow-up treatment guidelines. The report also simplifies the treatment algorithm and sheds light on new findings that suggest the use of pharmacological triple therapy can reduce mortality rates. Furthermore, the report includes discussions on inhaler device selection and adherence to COPD medications. These improvements demonstrate a continued effort to enhance COPD treatment and management. Although there are some areas that could benefit from more detailed guidance and explanation, such as the proper utilization of blood eosinophil counts for treatment decisions, and the establishment of treatment protocols post-hospitalization, the latest modifications to the GOLD recommendations will undoubtedly aid healthcare providers in addressing any gaps in patient care. We aim to highlight key changes in the GOLD 2023 report and present a viewpoint about their potential implications in a real-world clinical scenario.

Keywords: Bronchoscopy; Chronic obstructive lung disease; Computed tomography chest; Global initiative for chronic obstructive lung disease; Inhalers; Preserved ratio impaired spirometry.

PubMed Disclaimer

Conflict of interest statement

Salim Surani is the Co-Editor of the journal The Open Respiratory Medicine Journal.

Figures

Fig. (1)
Fig. (1)
Shows a simple recreation of ABE assessment tool and pharmacological options based on 2023 GOLD guidelines.
See this image and copyright information in PMC

References

    1. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442. - DOI - PMC - PubMed
    1. Tamondong-Lachica D.R., Skolnik N., Hurst J.R., Marchetti N., Rabe A.P.J., Montes de Oca M., Celli B.R. GOLD 2023 update: Implications for clinical practice. Int. J. Chron. Obstruct. Pulmon. Dis. 2023;18:745–754. doi: 10.2147/COPD.S404690. - DOI - PMC - PubMed
    1. Gayle A., Dickinson S., Morris K., Poole C., Mathioudakis A.G., Vestbo J. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs. Int. J. Chron. Obstruct. Pulmon. Dis. 2018;13:3485–3492. doi: 10.2147/COPD.S173664. - DOI - PMC - PubMed
    1. Palli S.R., Zhou S., Shaikh A., Willey V.J. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy. J. Manag. Care Spec. Pharm. 2021;27(5):625–637. doi: 10.18553/jmcp.2021.20390. - DOI - PMC - PubMed
    1. Agustí A., Celli B.R., Criner G.J., Halpin D., Anzueto A., Barnes P., Bourbeau J., Han M.K., Martinez F.J., Montes de Oca M., Mortimer K., Papi A., Pavord I., Roche N., Salvi S., Sin D.D., Singh D., Stockley R., López Varela M.V., Wedzicha J.A., Vogelmeier C.F. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur. Respir. J. 2023;61(4):2300239. doi: 10.1183/13993003.00239-2023. - DOI - PMC - PubMed

LinkOut - more resources